# Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma

> **NCT01590160** · PHASE1,PHASE2 · COMPLETED · sponsor: **University College, London** · enrollment: 27 (actual)

## Conditions studied

- Lung Cancer - Malignant Pleural Mesothelioma

## Interventions

- **DRUG:** Ganetespib

## Key facts

- **NCT ID:** NCT01590160
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2019-11-05
- **Final completion:** 2019-11-05
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2019-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01590160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01590160, "Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01590160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*